The only reason prices for EpiPens could be raised is that government regulations created a captive market whose regulations required the delivery system that Mylan Labs had patented.  Epinephrine, the actual product delivered to the bloodstream, is a hormone and not patentable.  The ease of use of Mylan’s EpiPen is worthwhile and can save seconds, especially if an inexperienced person is delivering the dosage. That ease of use costs you several hundred dollars.  If you are, for instance, a family with a child who has a condition that might require an EpiPen and you are willing to forego that convenience and follow a few instructions, you can purchase the capability of delivering that dosage for about ten bucks!  Christian Hauser of ABC22Now reports: A Miami Valley doctor wants parents to know they have alternatives to the costly EpiPen. Dr. Marcus Romanello is the Chief Medical Officer and the Emergency Medicine Physician at Ft....(Read Full Post)